RION, a clinical-stage regenerative medicine company at the forefront of exosome-based therapeutics, announced today that it has completed patient enrollment in its Phase 2 clinical trial for Purified ...

Amesanar is under clinical development by RHEACELL and currently in Phase II for Diabetic Foot Ulcers. According to GlobalData, Phase II drugs for Diabetic Foot Ulcers does not have sufficient ...

Foot problems span everything from wearing the wrong shoes to having a specific foot shape and acquiring infection or nerve ...

Allan Gayner has spoken out about the importance of spotting the signs of a potentially horrifying condition that could see ...

Diabetic Foot Disease is defined as a syndrome in which peripheral neuropathy and peripheral vascular disease may result in foot ...

A roundup of healthcare trends. FAU researchers test treatment for back pain; new machine treats enlarged prostate with an ...

If for perhaps no other reason, one must admire the Biden administration for its consistency; over the course of four years, ...

“Inadequately managed diabetes heightens infection risk, complicating ulcer treatment and potentially leading to severe consequences like gangrene and amputation if neglected. Consistent foot ...

The global diabetic foot ulcer treatment market was valued at USD 8.2 billion in 2022 and is expected to reach USD 14.4 billion by 2032. The majority of diabetic wound care products are passive ...

MolecuLight Inc., a global medical device company pioneering point-of-care fluorescence imaging for measuring bacterial load ...

Diabetic Charcot arthropathy with rocker bottom deformity and plantar midfoot ulcer. Management ... The goals of treatment include control of foot alignment and shape to achieve consolidation ...